Company Valuation: Elliptic Laboratories ASA

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 2,882 2,295 1,786 1,103 714.9 347.4 - -
Change - -20.36% -22.15% -38.24% -35.2% -51.4% - -
Enterprise Value (EV) 1 2,681 2,129 1,697 1,046 671.8 280.4 296.6 304.4
Change - -20.57% -20.32% -38.34% -35.79% -58.26% 5.77% 2.63%
P/E -252x -71.1x -47.3x 116x -5.14x -11.1x -55.7x 58.2x
PBR 8.41x 7.04x 5.82x 3.39x 3.8x 1.63x 1.64x 1.56x
PEG - -0x -2.9x -1x 0x 0.1x 0.7x -0x
Capitalization / Revenue 45.7x 44.1x 26.1x 8.36x 6.96x 3.4x 2.86x 2.3x
EV / Revenue 42.5x 40.9x 24.8x 7.93x 6.54x 2.74x 2.44x 2.01x
EV / EBITDA -948x -69.1x -50.6x 41.7x -32.5x -47.4x 16.9x 8.42x
EV / EBIT -241x -50.5x -34.1x 222x -14.8x -8.9x -33.7x 38.3x
EV / FCF -94.3x -59x - - -29.1x -11.2x -29.7x -304x
FCF Yield -1.06% -1.69% - - -3.44% -8.92% -3.37% -0.33%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.11 -0.31 -0.36 0.09 -1.32 -0.2475 -0.0494 0.0473
Distribution rate - - - - - - - -
Net sales 1 63.04 52.06 68.32 131.9 102.7 102.2 121.3 151.3
EBITDA 1 -2.829 -30.81 -33.52 25.12 -20.68 -5.917 17.56 36.17
EBIT 1 -11.14 -42.13 -49.74 4.71 -45.44 -31.5 -8.792 7.947
Net income 1 -11.16 -32.04 -37.85 8.96 -139 -32.05 -6.465 6.262
Net Debt 1 -201 -165.5 -89.72 -57.04 -43.06 -67.03 -50.86 -43.07
Reference price 2 27.750 22.050 17.040 10.480 6.790 2.750 2.750 2.750
Nbr of stocks (in thousands) 103,842 104,074 104,838 105,275 105,287 126,337 - -
Announcement Date 10/03/22 17/02/23 15/02/24 27/02/25 26/02/26 - - -
1NOK in Million2NOK
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-11.11x2.74x-47.39x-.--% 35.59M
-325.31x6.09x22.74x-.--% 22.52B
154.44x0.86x10.9x-.--% 7.42B
15.32x - - - 4.71B
60.92x1.53x11x-.--% 3.54B
22.3x2.2x10.69x1.49% 1.6B
22.36x - - - 448M
Average -8.73x 2.69x 1.59x 0.3% 5.75B
Weighted average by Cap. -145.19x 4.34x 18.44x 0.07%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ELABS Stock
  4. Valuation Elliptic Laboratories ASA